Profile
ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its lead program is a peptide drug conjugate for TOP1 resistant solid tumors and is in Phase I and at the best hospitals in North America and has begun dosing. Its platform has been validated (in-vivo and with unprecedented in-vitro characteristics) with four top 25 pharma companies in their experimental assays. ProteinQure is the only computational platform capable of designing peptides with the full complement of non-canonical amino acids, so that our peptides are 100x better than natural peptide ligands. For its own internal programs Protein Qure uses the novel peptides to help deliver payloads in a tissue specific manner. Peptides are ideal for delivery of different payloads like radioisotopes and gene therapy since they are tissue specific and easier to manufacture. ProteinQure also has exciting in-vivo POC for siRNA delivery to CNS.
Website
proteinqure.comContact
-
Lucas Siow, Chief Executive OfficerTel: +1 647-248-9772Email: lucas@proteinqure.com
-
-
-
-
-
Event details
Event contact
Participants
-
20/20 OptimEyes Technologies is developing OPT-101, a sustained-release glaucoma eye drop designed to reduce… -
APS Pharma™ is a Canadian innovation-focused specialty chemistry… -
AlloWide Health is an Ontario-based biotechnology company developing innovative solutions to improve the… -
Altis Labs is the AI endpoint company accelerating clinical trials. Altis has trained proprietary… -
Lumerate’s investor intelligence brand, tracks global life science deal flow to reveal behavioral signals that… -
BioScript Solutions is a Canadian healthcare company committed to simplifying access to specialty care. BioScript… -
Bough Bio is a pre-clinical stage company focused on decoding the molecular biology of senescent cells to unlock… -
Dalriada is a Canadian small molecule discovery company focusing on unlocking challenging and undruggable targets… -
Drug formulation has the power to transform promising compounds into life-saving therapies, yet this step is… -
JN Nova Pharma is a Canadian biotechnology company developing a proprietary platform technology to… -
Over 30% of organ transplant patients have complications due to CMV. Kanata… -
Medicenna Therapeutics is a clinical-stage immunotherapy company engineering next-generation cytokine therapies… -
Pattern’s patented PPI-100 activates innate immunity against cancers… -
PlantForm Corporation is a biopharmaceutical company focused on the rapid development and production of specialty… -
ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its lead…
-
Q&C Services is Canada’s largest independent full-service consultant and importer for pharmaceutical, natural… -
QurCan Therapeutics is advancing the next wave of genetic medicines for CNS… -
Rhythm Biotherapeutics develops first-in-class, heart-derived exosome therapeutics to prevent atrial fibrillation… -
Singularity Pharma is a drug discovery business developing novel therapeutics for… -
Specific Biologics is developing Dualase®, an industry-leading genome editing platform with best-in-class… -
Spiderwort is a platform biomaterials company developing a suite of cellulose-based scaffolds for use in a number… -
TheraVac Biologics is a late-stage preclinical company developing innovative immunotherapies for… -
Transpharmation is a contract research organisation led by scientists. Recognised by drug developers worldwide… -
Virano is a genetic immunomodulation company, developing next-generation combination products which reprogram the… -
YYZ Pharmatech Inc. (YYZ) is a deep tech company endeavoring to profoundly progress new medicine for…